BONEXBoneSupport Holding ABBONEX info
$29.64info1.74%24h
Global rank
Market cap$1.93B
Change 7d4.87%
YTD Performance71.85%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    BoneSupport Holding AB (BONEX) Stock Overview

    Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.

    BONEX Stock Information

    Symbol
    BONEX
    Address
    Scheelevägen 19Lund, 223 70Sweden
    Founded
    -
    Trading hours
    -
    Website
    https://www.bonesupport.com
    Country
    🇸🇪 Sweden
    Phone Number
    46 4 62 86 53 70

    BoneSupport Holding AB (BONEX) Price Chart

    -
    Value:-

    BoneSupport Holding AB Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $29.64
    N/A
    Market Cap
    $1.93B
    N/A
    Shares Outstanding
    65.06M
    N/A
    Employees
    105.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org